Evidence map›Paper›PMID 40963868›Full record

ArticleFrontiers in oncology2025

Bibliometric analysis of immunotherapy for esophageal cancer: 2004-2024.

Yunqi Hua, Yubo Liu, Yanhong Liu, Xiaoling Tian, Xinyi Zhang, Jiacong You, Fangrui Yin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yunqi Hua *Department of oncology, Baotou Cancer Hospital, Baotou, Inner Mongolia, China.
Yubo Liu *Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China.
Yanhong LiuBaotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China.
Xiaoling TianBaotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China.
Xinyi ZhangDepartment of oncology, Baotou Cancer Hospital, Baotou, Inner Mongolia, China.
Jiacong YouEditorial Office of Medical Journal of Peking Union Medical College Hospital, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing, China.
Fangrui YinDepartment of Rheumatology, The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal cancer (EC) remains one of the most lethal malignancies worldwide, with particularly high incidence and mortality rates in developing countries. In recent years, immunotherapy has emerged as a promising treatment strategy. This study employed bibliometric visualization tools, including CiteSpace and VOSviewer, to analyze research pertaining to immunotherapy in esophageal cancer. Based on 780 English-language publications indexed in the Web of Science database from 2004 to 2024, we quantitatively examined the research landscape, evolutionary trends, and knowledge structure of this field. The results indicated a steady increase in annual publications, with China being the leading contributor and Zhengzhou University as the most productive institution.

Indexed as

bibliometricsesophageal cancerimmunotherapyPD-1visualization

Identifiers

PMID40963868
PMCPMC12436129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.